Skip to main content

Financial Intermediaries

We base our success on our commitment to personal service and the virtues of quality, integrity and reliability.

Contact us
We create fully diversified portfolios that combine GAM’s expertise in asset allocation, fund manager research and active investment management. We then scale these portfolios to various risk levels to offer clients the most suitable investment products.
Charles Hepworth, Investment Director.

Resources

As markets change over time, we’re ready for the challenge. Independent and with a global presence, we have long recognised across all areas of our business that results beyond the ordinary can best be achieved by thinking beyond the obvious. Hear the latest views from our investment managers.

We have a comprehensive range of active investment strategies across asset classes and styles.

GAM EVENTS

Looking for interactive fund and market updates from GAM? Register for our upcoming virtual events.
Share the latest thoughts of our investment experts and access our extensive library of on demand webcasts.

Register here

Charles Hepworth's Blog

Charles Hepworth Blog
EU inflation falls to 2.4% in November
30 November 2023

Lower-than-expected EU CPI fuels speculation of interest rate cuts next year.

Charles Hepworth Blog
US Q3 GDP revised up to 5.2%
29 November 2023

Higher business investment and government spending lift growth to a level likely to worry policymakers, albeit consensus still says rates have peaked.

Charles Hepworth Blog
Key takeaways from the Chancellor’s Autumn Statement
22 November 2023

With the economy flatlining and an election looming, Jeremy Hunt announces a bigger-than-expected £20 billion giveaway, including cuts to business tax and National Insurance.

Thought leadership

Charles Hepworth Blog
EU inflation falls to 2.4% in November
30 November 2023

Lower-than-expected EU CPI fuels speculation of interest rate cuts next year.

Investment Opinions
The Disruptive Strategist: The rise of GLP-1 weight loss drugs
30 November 2023

GLP-1 weight loss drugs are transforming the healthcare scene. Some analysts are predicting that the anti-obesity market may become the largest pharmaceutical market in history, while on the other hand, share prices of medical device companies, particularly those specialising in diabetes and obesity management, are beginning to feel the pressure.

Charles Hepworth Blog
US Q3 GDP revised up to 5.2%
29 November 2023

Higher business investment and government spending lift growth to a level likely to worry policymakers, albeit consensus still says rates have peaked.

Podcasts

Podcasts
GAM Talks Podcast Episode Seven - Mark Hawtin and Amanda Lyons
02 October 2020

GAM Talks Podcast Episode Seven - Mark Hawtin and Amanda Lyons

Podcasts
GAM Talks Podcast Episode Six - Jeremy Smouha
14 May 2020

GAM Talks Podcast Episode Six - Jeremy Smouha

Podcasts
GAM Talks Podcast episode Five - Tom Mansley
04 February 2020

GAM Talks Podcast episode Five – Tom Mansley

Client Team

Please visit our Contacts and Locations page.